Viewing Study NCT00163150


Ignite Creation Date: 2025-12-24 @ 5:13 PM
Ignite Modification Date: 2025-12-29 @ 6:25 AM
Study NCT ID: NCT00163150
Status: COMPLETED
Last Update Posted: 2021-02-18
First Post: 2005-09-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Vasomotor Reactivity In Cerebral Small Vessel Disease And New Approach To Treat Lacunar Stroke
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2003-06
Start Date Type: None
Primary Completion Date: None
Primary Completion Date Type: None
Completion Date: 2006-02
Completion Date Type: ACTUAL
First Submit Date: 2005-09-09
First Submit QC Date: None
Study First Post Date: 2005-09-13
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2021-02-17
Last Update Post Date: 2021-02-18
Last Update Post Date Type: ACTUAL